Journal article

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

Jason Grebely, Sarah Larney, Amy Peacock, Samantha Colledge, Janni Leung, Matthew Hickman, Peter Vickerman, Sarah Blach, Evan B Cunningham, Kostyantyn Dumchev, Michael Lynskey, Jack Stone, Adam Trickey, Homie Razavi, Richard P Mattick, Michael Farrell, Gregory J Dore, Louisa Degenhardt

Addiction | WILEY | Published : 2019


Awarded by National Institute for Drug Abuse


Funding Acknowledgements

The Australian National Drug and Alcohol Research Centre, UNSW Sydney, provided some funding towards the costs of this systematic review. The Open Society Foundation, World Health Organization, the Global Fund, and UNAIDS provided funding towards the systematic review to estimate the number of people with recent injecting drug use and the HCV antibody prevalence among people who have recently injected drugs. The John C Martin Foundation provided funding towards the systematic review and modelling study to estimate the global viraemic HCV prevalence L.D. and R.P.M. are supported by Australian National Health and Medical Research Council (NHMRC) Principal Research Fellowships. S.L. is supported by an NHMRC Career Development Fellowship. A.P. is supported by an NHMRC Early Career Fellowship. J.L. acknowledges funding from the Bill & Melinda Gates Foundation. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. J.G. is supported by an NHMRC Career Development Fellowship. C.D. is supported by an NHMRC Practitioner Fellowship. J.S. acknowledges funding from a PhD scholarship from the Engineering and Physical Sciences Research Council (EPSRC). E.B.C. acknowledges funding from Canadian Network on Hepatitis C (CanHepC). A.T. has received PhD funding from the National Institute for Health Research (NIHR). M.H. and P.V. acknowledge support from NIHR Health Protection Research Unit (HPRU) in Evaluation of Interventions at the University of Bristol. P.V. acknowledges support from the NIHR HPRU in Blood-Borne and Sexually Transmitted Infections at University College London and National Institute for Drug Abuse (grant number R01 DA037773-01A1). We thank the research assistants who assisted with searches for and extraction of data from the eligible papers in this review: Erin Yong, Gabrielle Gibson, Griselda Buckland, Harriet Townsend, Julia Stadum and Laura Sergeant (NDARC, UNSW) and Diana Sergiienko (Ukrainian Institute of Public Health Policy). We also thank Mary Kumvaj, the librarian who provided specialist advice on our search strategy and search strings for the peer-reviewed literature searches. Finally, we thank the individuals who provided encouragement and support in various ways throughout the conduct of this study, including circulating requests for data, provision of in-country contacts and assistance with locating data: Annette Verster (WHO), Daniel Wolfe (Open Society Foundations), Andre Noor (EMCDDA), Eleni Kalamara (EMCDDA), Mauro Guarinieri (Global Fund), Christoforos Mallouris (UNAIDS), Susie McLean, Catherine Cook [Harm Reduction International(HRI)], Maria Phelan (HRI), Katie Stone (HRI), Riku Lehtovuori (UNODC), Keith Sabin (UNAIDS), Jinkou Zhao (Global Fund), Vladimir Poznyak (WHO) and Gilberto Gerra (UNODC). Assistance in sourcing and verifying data was provided by many individuals from government, non-government and research organizations around the world, for which we are thankful. These individuals are listed in the Appendix (p. 154).